Potential Use of Plasma Rich in Growth Factors in Age-Related Macular Degeneration: Evidence from a Mouse Model
Eduardo Anitua, Francisco Muruzabal, Sergio Recalde, Patricia Fernandez-Robredo, Mohammad Hamdan Alkhraisat · 2024
Read Potential Use of Plasma Rich in Growth Factors in Age-Related Macular Degeneration: Evidence from a Mouse Model by Eduardo Anitua, Francisco Muruzabal, Sergio Recalde, Patricia Fernandez-Robredo, Mohammad Hamdan Alkhraisat (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727663.txt.
Description
Age-related macular degeneration is the top cause of poor vision in rich countries, and its dry form still has no good treatment. Eduardo Anitua and four co-authors tested a blood-based therapy in mice in a 2024 study. The therapy, plasma rich in growth factors, is drawn from blood and carries proteins that help tissue heal.
The team harmed the mice's retinas with a chemical that mimics the disease, then injected the plasma or plain salt water into the eye. Photos of the retina at two and seven days showed less pigment loss in the treated group. Tissue checks found fewer signs of scarring activity and less invasion of the pigment layer by scar-forming cells. The authors read the results as early support for the therapy in dry degeneration.
Catalog record
| CREATOR | Eduardo Anitua, Francisco Muruzabal, Sergio Recalde, Patricia Fernandez-Robredo, Mohammad Hamdan Alkhraisat |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |